Metraipolis › archive › dc_fc12aa815f6b

Cancer-driver-agnostic targeting of amplified surface proteins identifies MPZL1 for selective CAR-T cell therapy — Europe PMC PMID:42722692

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42722692
DOI
10.1038/s41467-[numero omesso]-5
License (as archived)
solo-consultazione
Archived
2026-10-08T13:30:14.090Z
SHA-256 of the archived text
de97824d64afa9a2a74d0d130ea3ef1fee1b3fc6fc20bfcd3c55cb4d762ab810
Stable URL of this page
https://metraipolis.com/documento/dc_fc12aa815f6b

How to cite

Cancer-driver-agnostic targeting of amplified surface proteins identifies MPZL1 for selective CAR-T cell therapy — Europe PMC PMID:42722692 — Europe PMC (en), https://europepmc.org/article/MED/42722692 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_fc12aa815f6b (Metraipolis archive dc_fc12aa815f6b, sha256 de97824d64afa9a2a74d0d130ea3ef1fee1b3fc6fc20bfcd3c55cb4d762ab810)
BibTeX
@misc{dcfc12aa815f6b,
  title = {Cancer-driver-agnostic targeting of amplified surface proteins identifies MPZL1 for selective CAR-T cell therapy — Europe PMC PMID:42722692},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42722692},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_fc12aa815f6b; sha256 de97824d64afa9a2a74d0d130ea3ef1fee1b3fc6fc20bfcd3c55cb4d762ab810},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42722692. Agents can read the archived copy with the MCP tool read_document.